Clinical overview of Community Acquired Pneumonia, Hospital Acquired Pneumonia, Aspiration Pneumonia. Covers pathophysiology, clinical management, prevention, risk stratification (pneumonia severity index), prognostic factors, complications. Includes case studies, comprehension questions. Given at Jackson Park Medical Center on 12/1/2013. Includes references.
2. Question 1
An HIV+ patient with a CD-4+ count of 802 is
found to be hypoxic on room air. Chest X-ray
shows multi-lobular consolidation. What is the
most likely causative organism?
A. Moraxella catarrhalis
B. Klebsiella pneumoniae
C. Staphylococcus aureus
D. Streptococcus pneumoniae
E. Mycobacterium tuberculosis
Pre-Test
3. Question 2
A 47 year old homeless alcoholic male presents to
your clinic complaining of insidious onset dry cough.
He describes his sputum as “red jelly.” Chest x-ray
shows a bulging fissure. What is the most likely
diagnosis?
A. Aspiration Pneumonia
B. Acute Bronchitis
C. Ventilator Associated Pneumonia
D. Hospital Acquired Pneumonia
E. Adult Respiratory Distress Syndrome
Pre-Test
4. Question 3
A 62 year old male presents with a non-productive
cough of 2 weeks duration. Physical exam reveals
wheezing, rhonchi, crackles. The patient has a normal
pulse in but a high fever. What type of pneumonia is
most likely?
A. Typical Community Acquired Pneumonia
B. Hospital Acquired Pneumonia
C. Atypical Community Acquired Pneumonia
D. Ventilator Associated Pneumonia
Pre-Test
5. Question 4
An HIV+ patient who has a CD-4+ count of 52
presents with acute onset cough and fever. He
does not take antiretroviral meds or TMP-SMX,
is hypoxic on room air, and has a diffuse
bilateral infiltrate on chest film. What is the most
likely causative organism?
A. Streptococcus pneumoniae
B. Pneumocystis carinii
C. Aspergillis fumigatus
D. Coccidiodes
E. Mucormycosis
Pre-Test
6. Question 5
An elderly man presents w/ pneumonia, GI
disturbance, bradycardia, and hyponatremia. What
is the most likely causative organism?
A. Streptococcus pneumoniae
B. Staphlococcus aureus
C. Legionella pneumophilia
D. Coxiella burnetti
Pre-Test
7. Case Study
58 yo male presents to walk-in clinic c/o 24-hour history of fever, chills,
productive cough, and episode of rigors last night.
PMH: COPD, diabetes, smoking 2 packs/day (75 pack years lifetime).
Meds: combination steroid/long-acting beta agonist inhaler, tiotropium
bromide and albuterol, as needed.
Physical exam: tactile fremitus, expiratory wheezes and rhonchi.
Vitals: BP 168/92, HR 128, RR 32, T 101.3°F pulse oximetry 87% (RA).
Patient is placed on 4 liters O2, and albuterol via nebulizer. His O2 sat
increases to 94%, his RR decreases to 24, and pulse decreases to 112.
As the patient is still mildly hypoxic, tachypneic, tachycardic) and requiring
supplemental oxygen, he is admitted to a local hospital.
Chest x-ray reveals right lower lobe infiltrate and a white blood cell count
of 17,000/mm3. Sputum culture reveals S. pneumoniae.
The patient is placed on moxifloxacin 400 mg daily for 7 days and is started
on prednisone and albuterol via small-volume nebulizer.
He rapidly improves and is discharged 3 days later with instructions to finish
antibiotics/steroids and to follow-up with PCP.
Pre-Test
8. Pneumonia
Lower respiratory tract infection: Inflammatory
condition of the lung which primarily affects alveoli.
It is usually caused by infection
Typical symptoms include a cough, chest pain,
fever, and difficulty breathing
D/dx: URI, Acute Bronchitis, Lung Abscess
Epidemiology:
8th leading cause of death in the U.S.
Affects ~450 million people globally per year (seven
percent of the world population)
Results in ~4 million deaths worldwide, mostly in third-
world countries
Introduction
9. Classification
Community Acquired Pneumonia (CAP)
Occurs in the community or within the first 72 hours of
hospitalization; Can be typical or atypical
Most common bacterial pathogen is S. Pneumoniae (60%)
Hospital Acquired Pneumonia (HAP)
Occurs during hospitalization after first 72 hours
Gram-negative bacilli (Pseudomonas, Klebsiella, E. coli,
Enterobacter, Serratia, Acinetobacter, & S. aureus, including
MRSA)
Acid suppression (PPI use) may increase risk
Ventilator Associated Pneumonia
Aspiration Pneumonia
Chemical pneumonitis due to aspiration of gastric contents
Bacterial pneumonia ≥24–72 h later, due to aspiration of
oropharyngeal microbes
Outpatients: typical oral flora (Strep, S. aureus, anaerobes)
Inpatients or chronically ill: GNR and S. aureus
Introduction
10. Other Common Etiologies
Introduction
Presentation Cause
Young, Healthy Patients Mycoplasma, Chlamydia, Viral
Recent Viral Syndrome Staphylococcus Aureus
Alcoholics; Aspirators Klebsiella; other GNR
COPD H. influenzae, M. catarrhalis
Gastrointestinal Symptoms;
Confusion; Elderly; Smokers
Legionella
Persons present at the birth
of an animal
Coxiella burnetii
Arizona construction
workers
Coccidoidomycosis
HIV with <200 CD4+ cells Pneumocystis (PCP)
Nursing Home Resident Pseudomonas
11. Clinical Symptoms
“Typical” CAP
Acute onset of fever, productive cough w/ purulent
sputum, dyspnea, pleuritic pain
“Atypical” CAP: originally described as culture (-)
Insidious onset of dry (nonproductive) cough
Extrapulmonary sx: Nausea, Vomiting, diarrhea,
headache, myalgias, sore throat)
Ventilator Associated Pneumonia
Fever, Hypoxia
Increasing secretions
Work-Up
12. Clinical Signs
“Typical” CAP
Tachycardia, tachypnea
Late inspiratory crackles, bronchial breath
sounds, increased tactile and vocal fremitus,
dullness on percussion
Pleural friction rub: associated with pleural
effusion
“Atypical” CAP
Pulse–temperature dissociation: normal
pulse in the setting of high fever is suggestive
of atypical CAP.
Wheezing, rhonchi, crackles
Work-Up
13. Diagnosis
Best initial diagnostic test: Chest x-ray
Most accurate test: Sputum Gram stain
and Sputum Bacterial culture
Initial workup
1. All cases of respiratory disease (fever, cough,
sputum) should have a chest x-ray (PA &
Lateral) and oximeter ordered with the first
screen.
2. If there is shortness of breath, also order
oxygen with the first screen.
3. If there is shortness of breath and/or
hypoxia, order an ABG.
4. CBC w/ diff, Electrolytes, BUN/Cr, glc, LFTs
Work-Up
14. Imaging
Typical CAP – Lobar Consolidation on CXR
Atypical CAP - Patchy interstitial pattern on CXR
Work-Up
(From Erkonen WE, Smith WL. Radiology 101: The Basics and Fundamentals of Imaging.
Philadelphia, PA: Lippincott Williams & Wilkins, 1998:110, Figure 6-54A and B.)
15. Other Considerations
Additional microbiologic studies
Mycoplasma: PCR of throat or sputum/BAL before first abx
Legionella: urine Ag
S. pneumoniae: urinary Ag
MTb: induced sputum for AFB stain and mycobact. Cx
PCP: Induced sputum for PCP if HIV+ or known T cell-
mediated immunity; HIV test if 15–54 y
Bronchoscopy: consider if pt is immunosuppressed,
critically ill, failing to respond, or has chronic pneumonia.
Decision to Admit
Outpatient versus inpatient monitoring; ICU or no ICU.
The pneumonia severity index (PSI) is used to risk-stratify
In general elderly, hypoxic patients with or without a fever
should be admitted. Consider the ICU, depending on
severity of hypoxia.
Work-Up
16. Risk Factor PORT
Score
Sex
Men +Age (yrs)
Women +(Age-10)
Comorbidities
Nursing Home +10
Neoplasm +30
Liver Disease +20
CHF +10
CVA +10
Renal Disease +10
Exam ∆Mental Status +20
RR > 30 +20
SBP < 90 +20
T<35 or >40 +15
HR > 125 +10
Management
Risk Factor PSI Score
Labs
pH<7.35 +30
BUN>30 +20
Na<130 +20
Glucose>250 +10
Hct <30 +10
PaO2 <60 +10
SaO2<90 +10
Pleural
Effusion
+10
Risk Stratification
Pneumonia Severity
Index (PSI)
17. Prognosis
Clas
s
Total PSI Score Risk Mortality Suggested triage
I
<70 (Age 50, no
comorbidities)
Low 1% Outpatient
II <70 Low 1% Outpatient
III 71–90 Low 2.8% Brief inpatient
IV 91–130 Moderate 8.2% Inpatient
V >130 High 29.2% ICU
Management
18. Clinical scenario Empiric treatment guidelines
Outpatient No recent abx: macrolide OR doxycycline
Recent abx: [macrolide AND (high-dose amox
/clav or 2nd-gen. ceph.)] OR [respiratory FQ]
Community-acquired,
Hospitalized
[3rd-gen. ceph. AND macrolide] OR [respiratory
FQ]
Community-acquired,
hospitalized, ICU
[3rd-gen. ceph. or amp-sulbactam] AND
[macrolide or FQ] (assuming no risk for
Pseudomonas)
Hosp-acquired & risk
for MDR pathogens
[Antipseudomonal PCN or ceph. or
carbapenem] AND [FQ or (gentamicin
azithromycin)] AND [vancomycin or linezolid]
Immunosuppressed [As above] ± [TMP-SMX ] ± [steroids to cover
PCP]
Aspiration (3rd-gen. ceph. or FQ) ± [clindamycin or
metronidazole]
Treatment
19. Prevention
Pneumococcal Vaccine:
Persons >65 years of age
High-Risk medical illness (heart disease,
sickle cell disease, pulmonary disease,
diabetes, or alcoholic cirrhosis, or asplenic
individuals)
Influenza Vaccine: give yearly to people at
increased risk for complications and health
care workers
VAP precautions: HOB 30, chlorhexidine
rinse; aspiration precautions in high-risk Pts
Maintenance
20. Pleural effusion “parapneumonic effusions"
Can be seen in more than 50% of patients with CAP on
routine CXR. Empyema is infrequent in these patients.
Most of these effusions have an uncomplicated course
and resolve with treatment of the pneumonia with
antibiotics.
Thoracentesis should be performed if the effusion is
significant (>1 cm on lateral decubitus film). Send fluid for
Gram stain, culture, pH, cell count, determination of
glucose, protein, and LDH levels.
Pleural empyema occurs in 1% to 2% of all cases of
CAP (up to 7% of hospitalized patients with CAP). See
Chapter 2.
Acute respiratory failure may occur if the pneumonia
is severe.
Complications
21. Question 6
A 37 year old female presents with tachycardia,
tachypnea, late inspiratory crackles, bronchial breath
sounds, increased tactile and vocal fremitus, dullness
on percussion. What is the best initial test?
A. Arterial Blood Gas
B. Sputum Culture
C. Sputum Gram Stain
D. Chest X-ray
E. Spiral CT
Post-Test
22. Question 7
An otherwise healthy 29 year old male is
diagnosed with Community Acquired
Pneumonia on an outpatient basis. His PSI
score is <50. He states he has not recently
been on any antibiotics. What is the best first-
line therapy?
A. Ampicillin-Sulbactam
B. Ceftriaxone
C. Ceftriaxone and Ciprofloxacin
D. Doxycycline
E. Moxifloxacin
Post-Test
23. Question 8
A 34 year old male presents with pesistent dry
cough, weakness and malaise. Pulmonary infiltrates
are visualized on CXR. 3mL of patient’s blood is
added to anticoagulated tube and placed into ice
water. Several minutes later, clumping is detected
inside the tube. What is the most likely causative
organism?
A. Mycoplasma
B. Ureaplasma
C. Streptococcus pneumoniae
D. Pneumocystis carinii
Post-Test
24. Question 9
A 72 year old nursing home resident is admitted
for community-acquired pneumonia. The patient
is found to have a PSI Score of 140. What is the
patient’s relative mortality risk?
A. No Risk
B. Low Risk
C. Intermediate Risk
D. High Risk
Post-Test
25. Question 10
A 54 year old male smoker is admitted for
inpatient treatment of typical community-
acquired pneumonia. Excess fluid is visualized
between the visceral and parietal pleura on
CXR. What is the most likely complication?
A. Pleural Empyema
B. Pleural Emphysema
C. Pleural Effusion
D. Pleural Confusion
Post-Test
26. References
Arnold FW, Summersgill JT, Lajoie AS, et al. A worldwide perspective of atypical pathogens in
community-acquired pneumonia. Am J Respir Crit Care Med 2007; 175:1086.
File TM. Community-acquired pneumonia. Lancet 2003; 362:1991.
File TM Jr, Niederman MS. Antimicrobial therapy of community-acquired pneumonia. Infect Dis
Clin North Am 2004; 18:993.
Johnstone J, Mandell L. Guidelines and quality measures: do they improve outcomes of
patients with community-acquired pneumonia? Infect Dis Clin North Am 2013; 27:71.
Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology
(SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001;
56:296.
Malcolm C, Marrie TJ. Antibiotic therapy for ambulatory patients with community-acquired
pneumonia in an emergency department setting. Arch Intern Med 2003; 163:797.
Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American
Thoracic Society consensus guidelines on the management of community-acquired pneumonia
in adults. Clin Infect Dis 2007; 44 Suppl 2:S27.
Marrie TJ, Shariatzadeh MR. Community-acquired pneumonia requiring admission to an
intensive care unit: a descriptive study. Medicine (Baltimore) 2007; 86:103.
Marrie TJ, Poulin-Costello M, Beecroft MD, Herman-Gnjidic Z. Etiology of community-acquired
pneumonia treated in an ambulatory setting. Respir Med 2005; 99:60.
Read RC. Evidence-based medicine: empiric antibiotic therapy in community-acquired
pneumonia. J Infect 1999; 39:171.
Thank You!
Editor's Notes
D/dx
If nasal discharge, sore throat, or ear pain predominates, upper respiratory infection is likely.
clinical features (cough, sputum, fever, dyspnea) are not reliable in differentiating between pneumonia and acute bronchitis. CXR is the only reasonable method of differentiating between pneumonia and acute bronchitis.
VAP - Patients on mechanical ventilation are at risk of developing pneumonia because the normal mucociliary clearance of the respiratory tract is impaired (cannot cough). Also, positive pressure impairs the ability to clear colonization.
Most cases of CAP result from aspiration of oropharyngeal secretions because the majority of organisms that cause CAP are normal inhabitants of the pharynx.
Influenza A & B et al. (see “Viral Respiratory Infections”) (no organism identified in 40–60% cases)
Radiographic changes and clinical findings do not help in identifying the causative pathogen in CAP.
“Atypical” pneumonia refers to organisms not visible on Gram stain and not culturable on standard blood agar.
S/s & imaging do not reliably distinguish between “typical” (S. pneumo, H. flu) and “atypical” (Mycoplasma, Chlamydia, Legionella, viral)
Pleuritic chest pain (suggests pleural effusion)
Studies have shown that if vital signs are entirely normal, the probability of pneumonia in outpatients is less than 1%.
The following steps are appropriate in patients admitted to the hospital with suspected pneumonia:
• CXR (PA and lateral) Considered sensitive—If CXR findings are not suggestive of pneumonia, do not treat the patient with antibiotics.
• Gram stain and culture of sputum (confirmatory)
The value of routine sputum collection for Gram stain and culture is controversial (low sens/spec). The Infectious Disease Society of America has recently advocated performing sputum Gram stain and culture in all patients hospitalized with CAP.
A good sputum specimen has >25 PMNs and <10 epithelial cells per lowpower field.
A positive sputum culture is not pneumonia.
• Laboratory tests—CBC and differential, BUN, creatinine, glucose, electrolytes
• O2 saturation
• Two pretreatment blood cultures
• Antibiotic therapy
Typical: Changes include interstitial infiltrates, lobar consolidation, and/or cavitation. Multilobar consolidation indicates very serious illness.
Atypical: Diffuse reticulonodular infiltrates, Absent or minimal consolidation
VAP: New infiltrates on CXR
Chest PA (A) and lateral (B) radiographs: Right lower lobe pneumonia (straight arrows). On the PA radiograph, the right cardiac
border is clearly visible, and the right hemidiaphragm is partially silhouetted (double straight arrows). These findings indicate
that the infiltrate is posterior or in the right lower lobe as confirmed on the lateral radiograph (straight arrows).
CXR resolves in most by 6 wks; After treatment, changes evident on CXR usually lag behind the clinical response (up to 6 weeks). consider f/u to r/o underlying malignancy or other dx
False-negative chest radiographs occur with neutropenia, dehydration, infection with PCP (Pneumocystis carinii pneumonia), and early disease (<24 hours)
Legionella: urine Ag very sensitive, antigen persists for weeks (detects L. pneumophila L1 serotype, 60–70% of clinical disease), Elevated transaminases & decr. Na w/ Legionella
S. pneumoniae urinary Ag (Se 50–80%, Sp >90%)
MTb: induced sputum for AFB stain and mycobact. cx (empiric respiratory isolation while pending); avoid quinolones if considering TB; request rapid DNA probe if stain EB
PCP: silver stain, can also detect fungi
The decision to hospitalize or treat as an outpatient is probably the most
important decision to be made and is based on severity of disease
Patients are stratified into five classes based on severity (see Table 10-1). The Pneumonia Severity Index can serve as a general guideline, but clinical judgment is critical in making this decision. The decision to admit the patient is not based on a specific organism (one does not have this information when making this decision).
Treat outpatient pneumonia with: (continued for 5 days. Do not stop treatment until patient has been afebrile for 48 hours)
Macrolide (azithromycin, doxycycline, or clarithromycin)
Respiratory fluoroquinolone (levofloxacin, moxifloxacin)
Treat inpatient pneumonia with:
Ceftriaxone and azithromycin
Fluoroquinolone as a single agent
Treat ventilator-associated pneumonia (VAP) with:
lmipenem or meropenem, piperacillin/tazobactam or cefepime;
Gentamicin; and
Vancomycin or linezolid
Route of therapy InPts should initially be treated w/ IV abx to PO when clinically responding and able to take Pos
For low-risk Pts, can discharge immediately after switching to PO abx
*When possible, organism-directed therapy, guided by in vitro susceptibilities or local patterns of drug
resistance should be used. For ventilator-associated pneumonia, 8 15 d of Rx, except for Pseudomonas
and other non-fermenting GNR
Influenza vaccine—give yearly to people at increased risk for complications and
to health care workers
b. Pneumococcal vaccine—for patients >65 years and for younger people at high
risk (e.g., those with heart disease, sickle cell disease, pulmonary disease, diabetes,
or alcoholic cirrhosis, or asplenic individuals)
No recent abx: macrolide OR doxycycline
Recent abx: [macrolide AND (high-dose amox /clav or 2nd-gen. ceph.)] OR [respiratory FQ]
[3rd-gen. ceph. AND macrolide] OR [respiratory FQ]
[3rd-gen. ceph. or amp-sulbactam] AND [macrolide or FQ] (assuming no risk for Pseudomonas)